Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Sonoma Pharmaceuticals, Inc. (SNOA) had Normalized Income after Taxes of $-3.17M for the most recently reported fiscal year, ending 2026-03-31.
| Income Statement Financials | |
$19.53M |
|
$-3.17M |
|
$12.11M |
|
$7.42M |
|
$21.99M |
|
$-2.46M |
|
$-0.96M |
|
$-3.42M |
|
$-3.42M |
|
$-3.17M |
|
$-3.17M |
|
$-3.17M |
|
|
Normalized Income after Taxes |
$-3.17M |
$-2.46M |
|
$-2.32M |
|
1.68M |
|
1.68M |
|
$-1.89 |
|
$-1.89 |
|
| Balance Sheet Financials | |
$12.10M |
|
$0.31M |
|
$1.86M |
|
$13.96M |
|
$4.83M |
|
-- |
|
$6.03M |
|
$10.87M |
|
$3.10M |
|
$3.10M |
|
$3.10M |
|
1.80M |
|
| Cash Flow Statement Financials | |
$-3.93M |
|
$-0.19M |
|
$0.48M |
|
$5.37M |
|
$2.40M |
|
$-2.98M |
|
$0.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.50 |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
37.97% |
|
-12.60% |
|
-12.60% |
|
-11.89% |
|
-17.51% |
|
-16.26% |
|
$-4.12M |
|
-- |
|
-- |
|
-- |
|
1.40 |
|
3.32 |
|
7.73 |
|
47.23 |
|
-102.58% |
|
-102.58% |
|
-22.74% |
|
-102.58% |
|
$1.72 |
|
$-2.45 |
|
$-2.34 |
|